These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15344304)

  • 1. Cost effectiveness of human immunodeficiency virus postexposure prophylaxis for healthcare workers.
    Scheid DC; Hamm RM; Stevens KW
    Pharmacoeconomics; 2000 Oct; 18(4):355-68. PubMed ID: 15344304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.
    Pinkerton SD; Holtgrave DR; Pinkerton HJ
    Arch Intern Med; 1997 Sep; 157(17):1972-80. PubMed ID: 9308509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of HIV postexposure prophylaxis following sexual or injection drug exposure in 96 metropolitan areas in the United States.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    AIDS; 2004 Oct; 18(15):2065-73. PubMed ID: 15577628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
    Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of HIV post-exposure prophylaxis in France.
    Herida M; Larsen C; Lot F; Laporte A; Desenclos JC; Hamers FF
    AIDS; 2006 Aug; 20(13):1753-61. PubMed ID: 16931940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV.
    Pinkerton SD; Holtgrave DR; Bloom FR
    AIDS; 1998 Jun; 12(9):1067-78. PubMed ID: 9662204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-occupational postexposure prophylaxis for HIV: a systematic review.
    Bryant J; Baxter L; Hird S
    Health Technol Assess; 2009 Feb; 13(14):iii, ix-x, 1-60. PubMed ID: 19236820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S.
    Talbird SE; Brogan AJ; Winiarski AP
    Am J Prev Med; 2009 Nov; 37(5):381-8. PubMed ID: 19840692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.
    U.S. Public Health Service
    MMWR Recomm Rep; 2001 Jun; 50(RR-11):1-52. PubMed ID: 11442229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of short-course zidovudine to prevent perinatal HIV type 1 infection in a sub-Saharan African Developing country setting.
    Mansergh G; Haddix AC; Steketee RW; Nieburg PI; Hu DJ; Simonds RJ; Rogers M
    JAMA; 1996 Jul; 276(2):139-45. PubMed ID: 8656506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience of healthcare workers taking postexposure prophylaxis after occupational HIV exposures: findings of the HIV Postexposure Prophylaxis Registry.
    Wang SA; Panlilio AL; Doi PA; White AD; Stek M; Saah A
    Infect Control Hosp Epidemiol; 2000 Dec; 21(12):780-5. PubMed ID: 11140914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Public Health Service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 May; 47(RR-7):1-33. PubMed ID: 9603630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
    Mrus JM; Tsevat J
    Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of HIV Postexposure Prophylaxis in healthcare workers after occupational exposure: a Thai university hospital setting.
    Kiertiburanakul S; Wannaying B; Tonsuttakul S; Kehachindawat P; Apivanich S; Somsakul S; Malathum K
    J Med Assoc Thai; 2006 Jul; 89(7):974-8. PubMed ID: 16881429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?
    Mabileau G; Schwarzinger M; Flores J; Patrat C; Luton D; Epelboin S; Mandelbrot L; Matheron S; Yazdanpanah Y
    Am J Obstet Gynecol; 2015 Sep; 213(3):341.e1-12. PubMed ID: 25979615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Post-exposure HIV prevention within and outside the hospital].
    Jost J
    Ther Umsch; 1998 May; 55(5):289-94. PubMed ID: 9643126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis.
    Panlilio AL; Cardo DM; Grohskopf LA; Heneine W; Ross CS;
    MMWR Recomm Rep; 2005 Sep; 54(RR-9):1-17. PubMed ID: 16195697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.
    Ryan M; Griffin S; Chitah B; Walker AS; Mulenga V; Kalolo D; Hawkins N; Merry C; Barry MG; Chintu C; Sculpher MJ; Gibb DM
    AIDS; 2008 Mar; 22(6):749-57. PubMed ID: 18356605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers.
    D'Amico R; Pinto LA; Meyer P; Landay AL; Harris AA; Clerici M; Berzofsky JA; Shearer GM; Kessler HA
    Infect Control Hosp Epidemiol; 1999 Jun; 20(6):428-30. PubMed ID: 10395147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.